Search

Search Constraints

You searched for: Author/Creator Rowe, James B

Search Results

1. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study. Issue 2 (February 2020)

2. Atomoxetine and citalopram alter brain network organization in Parkinson's disease. Issue 1 (6th September 2019)

3. Atomoxetine and citalopram alter brain network organization in Parkinson's disease. Issue 1 (6th September 2019)

4. Atomoxetine and citalopram alter brain network organization in Parkinson's disease. Issue 1 (6th September 2019)

5. Atomoxetine and citalopram alter brain network organization in Parkinson's disease. Issue 1 (6th September 2019)

6. Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia. Issue 6 (9th April 2020)

7. [18F]AV-1451 binding in vivo mirrors the expected distribution of TDP-43 pathology in the semantic variant of primary progressive aphasia. Issue 10 (14th September 2017)

9. Multimodal imaging markers of tau, neuroinflammation and atrophy to predict clinical progression in progressive supranuclear palsy: Neuroimaging: Other neurodegenerative disorders. (7th December 2020)

10. Subtype and stage inference identifies distinct atrophy patterns in genetic frontotemporal dementia that MAP onto specific MAPT mutations: Imaging and non‐AD neurodegeneration. (7th December 2020)